A Safety and Efficacy Study of SABER®-Bupivacaine for Pain Following Hernia Repair
Status:
Completed
Trial end date:
2007-10-01
Target enrollment:
Participant gender:
Summary
This is a research study testing SABER-Bupivacaine (an experimental pain-relieving
medication). SABER-Bupivacaine is designed to continuously deliver bupivacaine, a common
local anesthetic, for a few days in order to treat local post-surgical pain. This study is
testing SABER-Bupivacaine in people having surgery to repair a hernia.
The purpose of the study is to measure and compare the safety (side effects), tolerability
(ability to tolerate), and efficacy (how well it works) of two different volumes of
SABER-Bupivacaine with SABER-Placebo.